PUBLICATIONS DATABASE
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
BMC Pulmonary Medicine
17 May 2016
Thys van der Molen, Dirkje Postma, Richard J Martin, Ron M.C. Herings, Jetty A. Overbeek, Victoria Thomas, Cristiana Miglio, Richard Dekhuijzen, Nicolas Roche, Theresa W Guilbert, Elliot Israel, Willem M.C. van Aalderen, Elizabeth V Hillyer, Simon van Rysewyk, David Price
Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
ERJ Open Research
1 April 2016
David Price, Gene Colice, Elliot Israel, Nicolas Roche, Dirkje Postma, Theresa W Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Vicky Thomas, Richard J Martin
Cost-effectiveness of asthma step-up therapy as an increased dose of extrafine-particle inhaled corticosteroid or add-on long-acting beta2-agonist
Pulmonary Therapy
21 March 2016
Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Paul M Dorinsky, Dirkje Postma, Theresa W Guilbert, Jonathan Grigg, Willem M.C. van Aalderen, Francesca Barion, Elizabeth V Hillyer, Victoria Thomas, Annie Burden, R. Brett McQueen, David Price
Reply [Inhaled corticosteroids for asthma therapy in young children: does aerosol particle size matter?
Journal of Allergy and Clinical Immunology: In Practice
2 March 2016
Willem M.C. van Aalderen, Jonathan Grigg, Theresa W Guilbert, Nicolas Roche, Gene Colice, Dirkje Postma, Elizabeth V Hillyer, David Price
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational
NPJ Primary Care Respiratory Medicine
26 February 2016
Kevin Gruffyd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
NPJ Primary Care Respiratory Medicine
25 February 2016
Kevin Gruffyd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting
Journal of Asthma
26 January 2016
Janine A.M. Westerik, Victoria Carter, Henry Chrystyn, Annie Burden, Samantha L. Thompson, Dermot Ryan, Kevin Gruffyd-Jones, John Haughney, Nicolas Roche, Federico Lavorini, Alberto Papi, Antonio Infantino, Miguel Román Rodríguez, Sinthia Bosnic-Anticevich, Karin Lisspers, Björn Ställberg, Svein Høegh Henrichsen, Thys van der Molen, Catherine Hutton, David Price
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
The Lancet Respiratory Medicine
19 October 2015
David Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew Wilson, Mary Buatti Small, Gokul Gopalan, Valerie L Ashton, Annie Burden, Elizabeth V Hillyer, Marjan Kerkhof, Ian Pavord
Current controversies and challenges in allergic rhinitis management
Expert Review of Clinical Immunology
29 August 2015
David Price, Peter Smith, Peter Hellings, Nikolaos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan, Jean Bousquet
Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma
Annals of the American Thoracic Society
1 June 2015
Elliot Israel, Nicolas Roche, Richard J Martin, Gene Colice, Paul M Dorinsky, Dirkje Postma, Theresa W Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidti, Victoria Thomas, David Price
Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma
Journal of Allergy and Clinical Immunology: In Practice
29 May 2015
Willem M.C. van Aalderen, Jonathan Grigg, Theresa W Guilbert, Nicolas Roche, Elliot Israel, Richard J Martin, Gene Colice, Dirkje Postma, Elizabeth V Hillyer, Annie Burden, Victoria Thomas, Julie von Ziegenweidti, David Price
Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma
American Journal of Respiratory and Critical Care Medicine
15 April 2015
Nicolas Roche, Dirkje Postma, Gene Colice, Annie Burden, Theresa W Guilbert, Elliot Israel, Richard J Martin, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Julie von Ziegenweidti, David Price
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
J Asthma Allergy
14 January 2015
David Price, Alan Kaplan, Rupert Jones, Daryl Freeman, Annie Burden, Shuna Gould, Julie von Ziegenweidti, Muzammil Ali, Christine King, Mike Thomas
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
International Journal of Chronic Obstructive Pulmonary Disease
17 October 2014
Dirkje Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem M.C. van Aalderen, Jonathan Grigg, Annie Burden, Elizabeth V Hillyer, Julie von Ziegenweidti, Gokul Gopalan, David Price
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
NPJ Primary Care Respiratory Medicine
9 October 2014
Richard J Martin, David Price, Nicolas Roche, Elliot Israel, Willem M.C. van Aalderen, Jonathan Grigg, Dirkje Postma, Theresa W Guilbert, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidti, Gene Colice